20Oct
Driving Revenue And Deal Flow Through An Intelligent IP Strategy: Strategies For Smaller And Early-Stage Life Science Companies. Part III: Choosing The Right Transaction
Part I described various strategies to help smaller and early-stage life science companies establish an intelligent IP strategy and Part II described various strategies used when preparing for a transaction. In this Part III, we discuss the various relevant factors for choosing the right transaction......
By:
Adler Pollock & Sheehan P.C.
Related
More than a year ago, in June 2018, the Pennsylvania Department of Labor and Industry (DLI) proposed...
Read More >
On Thursday, February 4, Senator Amy Klobuchar (D-MN), Chair of the Senate Judiciary Committee’s Su...
Read More >
Against a global backdrop that saw M&A slip 9% by both value and volume year on year, the financial ...
Read More >
Following the prime minister’s announcement that free movement will come to an end, the UK governme...
Read More >
The Massachusetts Supreme Judicial Court (SJC), the Commonwealth’s highest court, recently clarifie...
Read More >
BCLP’s global Antitrust & Competition team have been tracking the various ways COVID-19 is impactin...
Read More >